Compare AANJANEYA LIFECARE with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NATCO PHARMA DR. DATSONS LABS/
NATCO PHARMA
 
P/E (TTM) x -10.9 34.4 - View Chart
P/BV x 0.2 4.9 3.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   NATCO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NATCO PHARMA
Mar-19
DR. DATSONS LABS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs126849 14.8%   
Low Rs31557 5.5%   
Sales per share (Unadj.) Rs133.0573.8 23.2%  
Earnings per share (Unadj.) Rs0.2176.0 0.1%  
Cash flow per share (Unadj.) Rs6.6198.2 3.3%  
Dividends per share (Unadj.) Rs06.25 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8842.7 15.3%  
Shares outstanding (eoy) m31.6636.50 86.7%   
Bonus/Rights/Conversions FCCBBB-  
Price / Sales ratio x0.61.2 48.0%   
Avg P/E ratio x516.14.0 12,921.5%  
P/CF ratio (eoy) x11.83.5 333.9%  
Price / Book Value ratio x0.60.8 72.8%  
Dividend payout %03.6 0.0%   
Avg Mkt Cap Rs m2,47725,660 9.7%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m563,559 1.6%   
Avg. sales/employee Rs ThNM4,225.3-  
Avg. wages/employee Rs ThNM718.0-  
Avg. net profit/employee Rs ThNM1,295.9-  
INCOME DATA
Net Sales Rs m4,21120,945 20.1%  
Other income Rs m791,302 6.0%   
Total revenues Rs m4,28922,247 19.3%   
Gross profit Rs m5697,948 7.2%  
Depreciation Rs m204810 25.2%   
Interest Rs m430193 222.9%   
Profit before tax Rs m138,247 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,823 0.3%   
Profit after tax Rs m56,424 0.1%  
Gross profit margin %13.537.9 35.6%  
Effective tax rate %48.022.1 217.3%   
Net profit margin %0.130.7 0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85223,472 29.2%   
Current liabilities Rs m6,7117,287 92.1%   
Net working cap to sales %3.377.3 4.3%  
Current ratio x1.03.2 31.7%  
Inventory Days Days16192 174.5%  
Debtors Days Days31888 361.0%  
Net fixed assets Rs m3,67318,648 19.7%   
Share capital Rs m317365 86.7%   
"Free" reserves Rs m3,76134,525 10.9%   
Net worth Rs m4,07830,760 13.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63343,031 29.4%  
Interest coverage x1.043.7 2.4%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.5 68.5%   
Return on assets %3.415.4 22.4%  
Return on equity %0.120.9 0.6%  
Return on capital %7.727.4 28.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96411,536 8.4%   
Fx outflow Rs m6072,939 20.7%   
Net fx Rs m3578,597 4.2%   
CASH FLOW
From Operations Rs m1,3456,688 20.1%  
From Investments Rs m-2,256-6,122 36.8%  
From Financial Activity Rs m-1,200-509 235.7%  
Net Cashflow Rs m-2,11166 -3,198.0%  

Share Holding

Indian Promoters % 4.5 52.0 8.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 1.4 16.6 8.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.0 361.9%  
Shareholders   20,807 25,395 81.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  TORRENT PHARMA  BIOCON   

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends at Record High; Tata Motors and Adani Ports Among Top Nifty Gainers(Closing)

Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS